[1]
“Formulation development and evaluation of colon targeted delayed release methotrexate pellets for the treatment of colonic carcinoma”, Braz. J. Pharm. Sci., vol. 54, no. 4, p. e17222, Dec. 2018, doi: 10.1590/s2175-97902018000417222.